About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Quetiapine Fumarate Bipolar Maintenance Monotherapy

Quetiapine Fumarate Bipolar Maintenance Monotherapy

NCT00314184·95 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

AstraZeneca

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Signed informed consent
18 years or older
A diagnosis of Bipolar I Disorder
Have a current manic, depressed or mixed episode
Have had a manic, depressed or mixed episode during the last 26 weeks that was treated with quetiapine
Female patients of childbearing potential must be using a reliable method of contraception

You may not be if

Pregnancy
Substance or alcohol dependence at enrollment
Unstable thyroid function
Unstable Diabetes
Unstable or inadequately treated medical illness e.g., angina pectoris and hypertension
Use of an experimental drug within 30 days of enrollment

The record

StatusCompleted

PhasePhase 3

Taking part1,255

StartedMar 2005

UpdatedDec 22, 2008

Conditions

Bipolar Disorder

Where95

Research Site
Cerritos, California, United States
Research Site
San Diego, California, United States
Research Site
Santa Ana, California, United States